| Literature DB >> 32941481 |
Yosuke Hatakeyama1, Shigeru Fujita1, Shuhei Iida2,3,4, Yoji Nagai2,5, Yoshiko Shimamori6, Junko Ayuzawa7, Tomohiro Hirao8, Ryo Onishi1, Kanako Seto1, Kunichika Matsumoto1, Tomonori Hasegawa1.
Abstract
Various patient safety interventions have been implemented since the late 1990s, but their evaluation has been lacking. To obtain basic information for prioritizing patient safety interventions, this study aimed to extract high-priority interventions in Japan and to identify the factors that influence the setting of priority. Six perspectives (contribution, dissemination, impact, cost, urgency, and priority) on 42 patient safety interventions classified into 3 levels (system, organizational, and clinical) were evaluated by Japanese experts using the Delphi technique. We examined the relationships of the levels and the perspectives on interventions with the transition of the consensus state in rounds 1 and 3. After extracting the high-priority interventions, a chi-squared test was used to examine the relationship of the levels and the impact/cost ratio with high priority. Regression models were used to examine the influence of each perspective on priority. There was a significant relationship between the level of interventions and the transition of the consensus state (p = 0.033). System-level interventions had a low probability of achieving consensus. "Human resources interventions," "professional education and training," "medication management/reconciliation protocols," "pay-for performance (P4P) schemes and financing for safety," "digital technology solutions to improve safety," and "hand hygiene initiatives" were extracted as high-priority interventions. The level and the impact/cost ratio of interventions had no significant relationships with high priority. In the regression model, dissemination and impact had an influence on priority (β = -0.628 and 0.941, respectively; adjusted R-squared = 0.646). The influence of impact and dissemination on the priority of interventions suggests that it is important to examine the dissemination degree and impact of interventions in each country for prioritizing interventions.Entities:
Mesh:
Year: 2020 PMID: 32941481 PMCID: PMC7497979 DOI: 10.1371/journal.pone.0239179
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
42 patient safety interventions.
| Level | Intervention |
|---|---|
| System | |
| Safety Standards | |
| Public reporting of patient safety indicators | |
| Mandatory reporting of specified adverse events | |
| Pay-for performance (P4P) schemes and financing for safety | |
| Professional education and training | |
| Electronic Health Record (EHR) systems | |
| No-fault medical harm compensation scheme | |
| System-level public engagement and health literacy initiatives | |
| Theme-based national safety initiatives | |
| A national agency responsible for patient safety | |
| Organization | |
| Clinical governance frameworks and systems for patient safety | |
| Clinical incident reporting and management system | |
| Integrated patient complaint- and incident-reporting | |
| Monitoring and feedback of patient safety indicators | |
| Patient-engagement initiatives | |
| Clinical communication protocols and training | |
| Digital technology solutions to improve safety | |
| Human resources interventions | |
| Building a positive safety culture | |
| Infection detection, reporting and surveillance systems | |
| Hand hygiene initiatives | |
| Antimicrobial stewardship | |
| Blood and blood product management protocols | |
| Medical equipment sterilisation protocols | |
| Clinical | |
| Medication management / reconciliation protocols | |
| Transcribing error systems and protocols | |
| Smart infusion pumps and drug administration systems | |
| Aseptic technique protocols and barrier precautions | |
| Urinary catheter use and insertion protocols | |
| Central venous catheter insertion protocols | |
| Ventilator-associated pneumonia minimisation protocols | |
| Procedural / surgical checklists | |
| Operating room integration and display technology | |
| Peri-operative medication protocols | |
| Venous thromboembolism (VTE) prevention protocols | |
| Clinical care standards | |
| Pressure injury (ulcer) prevention protocols | |
| Falls prevention initiatives | |
| Acute delirium & cognitive impairment management initiatives | |
| Response to clinical deterioration | |
| Patient hydration and nutrition standards | |
| Patient identification and procedure matching protocols |
Baseline characteristics of experts.
| n | % | ||
|---|---|---|---|
| Domain | |||
| Representative of Nationwide Organization related to Patient Safety | 2 | 8.3 | |
| Hospital Administrator | 5 | 20.8 | |
| Patient Safety Manager | 7 | 29.2 | |
| Researcher of Patient Safety | 8 | 33.3 | |
| Other | 2 | 8.3 | |
| Gender | |||
| Male | 18 | 75.0 | |
| Female | 6 | 25.0 | |
| Profession | |||
| Doctor | 15 | 62.5 | |
| Nurse | 4 | 16.7 | |
| Pharmacist | 2 | 8.3 | |
| Other | 3 | 12.5 | |
Relationship between the level of interventions and the transition of the consensus in rounds 1 and 3.
| Level | Consistent consensus | Change to consensus | Change to dissensus | Consistent dissensus | Total | |
|---|---|---|---|---|---|---|
| System | n | 27 | 18 | 0 | 5 | 50 |
| % | 54.0% | 36.0% | 0.0% | 10.0% | 100.0% | |
| Adj. Res | -2.36 | 1.42 | -0.56 | 2.62 | ||
| p | 0.018 | 0.154 | 0.575 | 0.009 | ||
| Organizational | n | 46 | 21 | 1 | 2 | 70 |
| % | 65.7% | 30.0% | 1.4% | 2.9% | 100.0% | |
| Adj. Res | -0.42 | 0.43 | 1.42 | -0.51 | ||
| p | 0.677 | 0.664 | 0.156 | 0.610 | ||
| Clinical | n | 69 | 20 | 0 | 1 | 90 |
| % | 76.7% | 22.2% | 0.0% | 1.1% | 100.0% | |
| Adj. Res | 2.43 | -1.64 | -0.87 | -1.77 | ||
| p | 0.015 | 0.101 | 0.385 | 0.077 | ||
| Total | n | 142 | 59 | 1 | 8 | 210 |
| % | 67.6% | 28.1% | 0.5% | 3.8% | 100.0% |
Chi-squared was 13.723 (p = 0.033). Abbreviations: Adj. Res = Adjusted Residuals.
Priority, impact, and cost of interventions (ordered by priority).
| High-Priority Interventions | Level | Priority | Impact | Cost | Impact/Cost Ratio |
|---|---|---|---|---|---|
| Human resources interventions | Organizational | 4.25 | 3.83 | 4.33 | 0.88 |
| Professional education and training | System | 4.25 | 3.92 | 3.38 | 1.16 |
| Medication management/ reconciliation protocols | Clinical | 4.22 | 4.13 | 3.57 | 1.16 |
| Pay-for performance (P4P) schemes and financing for safety | System | 4.08 | 3.83 | 3.75 | 1.02 |
| Digital technology solutions to improve safety | Organizational | 4.04 | 4.04 | 4.71 | 0.86 |
| Hand hygiene initiatives | Organizational | 4.00 | 4.08 | 3.13 | 1.30 |
| Transcribing error systems and protocols | Clinical | 3.96 | 4.00 | 3.75 | 1.07 |
| Response to clinical deterioration | Clinical | 3.91 | 3.83 | 3.48 | 1.10 |
| Acute delirium & cognitive impairment management initiatives | Clinical | 3.91 | 3.65 | 3.00 | 1.22 |
| Clinical communication protocols and training | Organizational | 3.91 | 3.87 | 3.04 | 1.27 |
| Patient identification and procedure matching protocols | Clinical | 3.79 | 3.92 | 2.54 | 1.54 |
| Procedural/surgical checklists | Clinical | 3.79 | 3.96 | 2.79 | 1.42 |
| Antimicrobial stewardship | Organizational | 3.79 | 3.88 | 3.08 | 1.26 |
| Venous thromboembolism (VTE) prevention protocols | Clinical | 3.78 | 3.96 | 3.35 | 1.18 |
| Peri-operative medication protocols | Clinical | 3.74 | 3.87 | 2.91 | 1.33 |
| Central venous catheter insertion protocols | Clinical | 3.71 | 4.00 | 3.63 | 1.10 |
| Infection detection, reporting, and surveillance systems | Organizational | 3.71 | 3.92 | 3.58 | 1.09 |
| Clinical governance frameworks and systems for patient safety | Organizational | 3.67 | 3.75 | 3.13 | 1.20 |
| Clinical care standards | Clinical | 3.65 | 3.74 | 3.04 | 1.23 |
| Patient-engagement initiatives | Organizational | 3.65 | 3.61 | 3.00 | 1.20 |
| Aseptic technique protocols and barrier precautions | Clinical | 3.63 | 4.00 | 3.96 | 1.01 |
Scores by the level of interventions in each perspective.
| Perspective | Level | Mean | SD | Median | IQR |
|---|---|---|---|---|---|
| Contribution | All | 3.10 | 0.39 | 3.14 | 0.65 |
| System | 2.96 | 0.52 | 3.09 | 0.84 | |
| Organizational | 3.10 | 0.40 | 2.94 | 0.81 | |
| Clinical | 3.18 | 0.30 | 3.17 | 0.51 | |
| Dissemination | All | 3.17 | 0.54 | 3.15 | 0.85 |
| System | 2.84 | 0.61 | 2.96 | 1.11 | |
| Organizational | 3.19 | 0.59 | 3.06 | 1.12 | |
| Clinical | 3.33 | 0.38 | 3.28 | 0.75 | |
| Impact | All | 3.72 | 0.27 | 3.79 | 0.32 |
| System | 3.56 | 0.28 | 3.61 | 0.49 | |
| Organizational | 3.75 | 0.27 | 3.81 | 0.29 | |
| Clinical | 3.80 | 0.23 | 3.83 | 0.31 | |
| Cost | All | 3.43 | 0.53 | 3.31 | 0.65 |
| System | 3.74 | 0.57 | 3.61 | 0.89 | |
| Organizational | 3.33 | 0.55 | 3.13 | 0.45 | |
| Clinical | 3.33 | 0.46 | 3.31 | 0.66 | |
| Urgency | All | 3.49 | 0.32 | 3.56 | 0.54 |
| System | 3.32 | 0.37 | 3.19 | 0.60 | |
| Organizational | 3.50 | 0.33 | 3.51 | 0.47 | |
| Clinical | 3.56 | 0.27 | 3.62 | 0.44 | |
| Priority | All | 3.59 | 0.36 | 3.61 | 0.50 |
| System | 3.45 | 0.41 | 3.38 | 0.52 | |
| Organizational | 3.63 | 0.38 | 3.66 | 0.50 | |
| Clinical | 3.63 | 0.32 | 3.68 | 0.37 |
Scores for contribution were calculated from the results of round 1, and the others from those of round 3.
Abbreviations: SD = Standard Deviation, IQR = Interquartile Range.
Correlation between the six perspectives (Spearman’s correlation coefficients).
| Contribution | Dissemination | Impact | Cost | Urgency | Priority | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Contribution | 1.000 | |||||||||
| Dissemination | 0.904 | 1.000 | ||||||||
| Impact | 0.502 | 0.476 | 1.000 | |||||||
| Cost | 0.036 | -0.089 | 0.189 | 1.000 | ||||||
| Urgency | 0.072 | -0.017 | 0.727 | 0.205 | 1.000 | |||||
| Priority | 0.074 | -0.008 | 0.719 | 0.153 | 0.960 | 1.000 | ||||
***p<0.001
**p<0.01
*p<0.05.
The influence of contribution, dissemination, impact, and cost on priority (standardized coefficients).
| Perspectives | Model 1 | Model 2 | Model 3 | Model 4 | |||
|---|---|---|---|---|---|---|---|
| Contribution | 0.600 | 0.103 | 0.177 | ||||
| Dissemination | -0.548 | -0.504 | -0.628 | ||||
| Impact | 0.710 | 0.893 | 0.941 | ||||
| Cost | 0.060 | -0.141 | |||||
| Adj. R-Squared | 0.509 | 0.030 | 0.639 | 0.646 | |||
Objective variables: Priority.
***p<0.001
**p<0.01
*p<0.05.